Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             158 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Achievements and Challenges in Antiviral Drug Discovery Littler, Eddy
2005
3 p. 155-168
artikel
2 Action of Celgosivir (6 O-Butanoyl Castanospermine) against the Pestivirus BVDV: Implications for the Treatment of Hepatitis C Whitby, Kevin
2004
3 p. 141-151
artikel
3 Activity of Isatine-Sulfadimidine Derivatives against 2009 Pandemic H1N1 Influenza Virus in Cell Culture Selvam, Periyasamy
2010
3 p. 143-146
artikel
4 Acyclic Phosphonomethylether Nucleoside Inhibitors of Respiratory Viruses Barnard, DL
1997
3 p. 223-233
artikel
5 Amino Acid Ester Prodrugs of Acyclovir Beauchamp, L. M.
1992
3 p. 157-164
artikel
6 Anionic Liposomes Inhibit Human Immunodeficiency Virus Type 1 (HIV-1) Infectivity in CD4+ A3.01 and H9 Cells Konopka, K.
1993
3 p. 179-187
artikel
7 Anticytomegalovirus Activity of Pristimerin, a Triterpenoid Quinone Methide Isolated from Maytenus Heterophylla (Eckl. & Zeyh.) Murayama, Tsugiya
2007
3 p. 133-139
artikel
8 Antiherpes Effect of Dextran Sulphate Combined with Acyclovir in vitro and in vivo Pancheva, S. N.
1993
3 p. 189-191
artikel
9 Anti-Herpes Simplex Virus Type 1 Activity of Humic Acid-Like Polymers and Their O-Diphenolic Starting Compounds Helbig, B
1997
3 p. 265-273
artikel
10 Anti-HIV-1 Activity of CD4 Synthetic Oligopeptides Representative of the Putative gp120 Binding Site Cereda, P. M.
1991
3 p. 157-161
artikel
11 Anti-HIV and anti-HCMV Activities of New Aurintricarboxylic Acid Analogues Cushman, M.
1995
3 p. 179-186
artikel
12 Anti-Human Cytomegalovirus Activity of Constituents from Sasa Albo-Marginata (Kumazasa in Japan) Sakai, Asumi
2008
3 p. 125-132
artikel
13 Anti-Human Immunodeficiency Virus Activity, Bioavailability and Drug Resistance Profile of the Novel Proteinase Inhibitor MDL 74,695 Taylor, DL
1997
3 p. 205-214
artikel
14 Anti-Human Immunodeficiency Virus Drug Combination Strategies Vandamme, A-M
1998
3 p. 187-203
artikel
15 Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Activity of 2′-fluoro-2′,3′-Dideoxyarabinosyladenine (F-ddA) Used in Combination with other Mechanistically Diverse Inhibitors of HIV-1 Replication Buckheit, RW
1999
3 p. 115-119
artikel
16 Antiviral Activities and Pharmacokinetics of Penciclovir and Famciclovir in Pekin Ducks Chronically Infected with Duck Hepatitis B Virus Tsiquaye, K.N.
1996
3 p. 153-159
artikel
17 Antiviral Activity against VZV and HSV Type 1 and Type 2 of the (+) and (−) Enantiomers of (R,S)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine, in Comparison to other Closely Related Acyclic Nucleosides Abele, G.
1991
3 p. 163-169
artikel
18 Antiviral Activity of 2-Hydroxy Fatty Acids Harper, D.R.
1996
3 p. 138-141
artikel
19 Antiviral Activity of low-MW Dextran Sulphate (Derived from dextran MW 1000) Compared to Dextran Sulphate Samples of Higher MW Witvrouw, M.
1991
3 p. 171-179
artikel
20 Antiviral Agents Derived from Novel 1-adamantyl Singlet Nitrenes Kesel, Andreas J
2013
3 p. 113-128
artikel
21 Antiviral and Virucidal Activities against Arenaviruses of Zinc-Finger Active Compounds Garcia, CC
2000
3 p. 231-237
artikel
22 Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st Edition) De Clercq, Erik
2006
3 p. 113-114
artikel
23 Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st Edition) Field, Hugh J
2006
3 p. 111-112
artikel
24 Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st Edition) the DNA Viruses 2006
3 p. 117-136
artikel
25 Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st edition) the RNA viruses 2006
3 p. 129-144
artikel
26 Antiviral Chemistry & Chemotherapy's Current Antiviral Agents FactFile 2006 (1st edition): The RNA Viruses with DNA Intermediates (Retroviruses) 2006
3 p. 139-168
artikel
27 Antiviral Synergy between Inhibitors of HIV Proteinase and Reverse Transcriptase Craig, J. C.
1993
3 p. 161-166
artikel
28 Are the 2-Isomers of the Drug Rimantadine Active Anti-Influenza a Agents? Zoidis, Grigoris
2003
3 p. 153-164
artikel
29 Arylketotetramethylene Analogues of Disoxaril with Anti-Human Rhinovirus 14 Activity Mai, A
1997
3 p. 235-242
artikel
30 A Stereochemical Rationale for the Activity of Anti-HIV Nucleosides Taylor, E. W.
1990
3 p. 163-173
artikel
31 Attempt to Reduce Cytotoxicity by Synthesizing the L-Enantiomer of 4′-C-Ethynyl-2′-Deoxypurine Nucleosides as Antiviral Agents against HIV and HBV Kitano, Kenji
2004
3 p. 161-167
artikel
32 Bevirimat: A Novel Maturation Inhibitor for the Treatment of HIV-1 Infection Martin, David E
2008
3 p. 107-113
artikel
33 Bicyclic Nucleoside Inhibitors of Varicella-Zoster Virus (VZV): Pd-Catalysed Synthesis of 5-aryl Derivatives and Their Biological Evaluation Carangio, A
2001
3 p. 187-197
artikel
34 Binding Modes of Two Novel Non-Nucleoside Reverse Transcriptase Inhibitors, YM-215389 and YM-228855, to HIV Type-1 Reverse Transcriptase Kodama, Eiichi
2008
3 p. 133-141
artikel
35 Biological activity and DNA Sequence Specificity of Synthetic Carbamoyl Analogues of Distamycin Alfieri, A
1997
3 p. 243-254
artikel
36 Cell-Based and Animal Models for Hepatitis B and C Viruses Schinazi, Raymond F
1999
3 p. 99-114
artikel
37 Characterization and Treatment of Cidofovir-Resistant Vaccinia (WR Strain) Virus Infections in Cell Culture and in Mice Smee, Donald F
2005
3 p. 203-211
artikel
38 Characterization of gp120 Binding to the CD4 Antigen and Detection of Specific Inhibitors Kozlowski, M. R.
1990
3 p. 175-182
artikel
39 Characterization of Hepatitis B Virus Inhibition by Novel 2′-Fluoro-2′,3′-Unsaturated Beta-D- and l-nucleosides Pai, S Balakrishna
2005
3 p. 183-192
artikel
40 Cidofovir, a New Agent with Potent Anti-Herpesvirus Activity Hitchcock, M. J. M.
1996
3 p. 115-127
artikel
41 Clinical Utility of Current NNRTIs and Perspectives of New Agents in This Class under Development Zhang, Zhijun
2004
3 p. 121-134
artikel
42 Cytokines and HIV-1: Interactions and Clinical Implications Kedzierska, Katherine
2001
3 p. 133-150
artikel
43 Dextrin Sulphate and Fucoidan are Potent Inhibitors of HIV Infection in vitro McClure, M. O.
1991
3 p. 149-156
artikel
44 3,7-Dideazaneplanocin: Synthesis and antiviral analysis Yin, Xue-Qiang
2017
3 p. 90-93
artikel
45 2′,3′-Didehydro-2′,3′-dideoxythymidine (D4T), an anti-HIV Agent Hitchcock, M. J. M.
1991
3 p. 125-132
artikel
46 Effect of Herpesvirus Inhibition on Primary SIV Infection in Cynomolgus Monkeys Böttiger, D.
1996
3 p. 160-166
artikel
47 Effect of Inhibitors of Protein Myristoylation on Varicella-Zoster Virus Replication Gilbert, R. L.
1994
3 p. 182-186
artikel
48 Effect of Intramuscularly Injected Polyprenols on Influenza Virus Infection in Mice Safatov, AS
2000
3 p. 239-247
artikel
49 Effect of Oral Gavage Treatment with ZnAL42 and other Metallo-Ion Formulations on Influenza a H5N1 and H1N1 Virus Infections in Mice Barnard, Dale L
2007
3 p. 125-132
artikel
50 Effects of Aryl Substituents on the Anti-HIV Activity of the Arylphosphoramidate Derivatives of Stavudine Uckun, Fatih M
2002
3 p. 197-203
artikel
51 Effects of a Specific Inhibitor of HIV Proteinase (Ro 31-8959) on Virus Maturation in a Chronically Infected Promonocytic Cell Line (U1) Craig, J. C.
1991
3 p. 181-186
artikel
52 Efficacy and Toxicity of Long-Term Administration of 2′,3′-dideoxycytidine in the LP-BM5 Murine-Induced Immunodeficiency Model Brandi, G.
1995
3 p. 153-161
artikel
53 Efficacy of Orally Administered Low Dose N-methanocarbathymidine against Lethal Herpes Simplex Virus Type-2 Infections of Mice Quenelle, Debra C
2011
3 p. 131-137
artikel
54 Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors Baba, Masanori
2017
3 p. 83-89
artikel
55 Exploration of the in vitro Antiviral Activity of a Series of New Pyrimidine Analogues on the Replication of HIV and HCV Jafar, Nadhir NA
2013
3 p. 103-112
artikel
56 Factors Affecting Template Usage in the Development of K65R Resistance in Subtype C Variants of HIV Type-1 Coutsinos, Dimitrios
2010
3 p. 117-131
artikel
57 Flavonoids: Potent Inhibitors of Poliovirus RNA Synthesis González, M. E.
1990
3 p. 203-209
artikel
58 Frequent Occurrence of HIV-Inhibitory Sulphated Polysaccharides in Marine Invertebrates Beutler, J. A.
1993
3 p. 167-172
artikel
59 Further Characterization of the Potent and Prolonged Inhibition of Herpes Simplex Virus Replication in Human Cell Lines by Penciclovir Bacon, T.H.
1996
3 p. 128-137
artikel
60 FV-100: The Most Potent and Selective Anti-Varicella Zoster Virus Agent Reported to Date Migliore, Marco
2010
3 p. 107-115
artikel
61 Ganciclovir and Penciclovir, but Not Acyclovir, Induce Apoptosis in Herpes Simplex Virus Thymidine Kinasetransformed Baby Hamster Kidney Cells Shaw, MM
2001
3 p. 175-186
artikel
62 Haloalkyl Phosphate Derivatives of AZT as Inhibitors of HIV: Studies in the Phosphate Region McGuigan, C.
1994
3 p. 162-168
artikel
63 Halophenyl Furanopyrimidines as Potent and Selective Anti-VZV Agents McGuigan, Christopher
2003
3 p. 165-170
artikel
64 Helicase Primase: Targeting the Achilles Heel of Herpes Simplex Viruses Kleymann, Gerald
2004
3 p. 135-140
artikel
65 HIV-1 Integrase Inhibitors: A Review of Their Chemical Development Ingale, Kundan B
2011
3 p. 95-105
artikel
66 HIV Replication in CD4-Negative Cell Lines: Effect of Cloning, CD4 Expression and Inhibition by Dextrin Sulphate Beddows, S.
1993
3 p. 173-177
artikel
67 Human T-cell Lymphotropic Viruses: Review and Prospects for Antiviral Therapy Palker, T. J.
1992
3 p. 127-139
artikel
68 Imidazo[1,5-b]Pyridazine-D4T Conjugates: Synthesis and Anti-Human Immunodeficiency Virus Evaluation Renoud-Grappin, M
1998
3 p. 205-223
artikel
69 Important Advances in the Field of Anti-Dengue Virus Research Julander, Justin G
2011
3 p. 105-116
artikel
70 Incorporation of Selected Nucleoside Phosphonates and Anti-Human Immunodeficiency Virus Nucleotide Analogues into DNA by Human DNA Polymerases α, β and γ Cihlar, T
1997
3 p. 187-195
artikel
71 Influenza Nucleoprotein: Promising Target for Antiviral Chemotherapy Cianci, Christopher
2013
3 p. 77-91
artikel
72 Inhibition of Hepatitis B Virus Gene Expression and Replication by Helioxanthin and its Derivative Li, Ying
2005
3 p. 193-201
artikel
73 Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and 9-(R)-2-(Phosphono Methoxypropyl)adenine Franchetti, P
2001
3 p. 151-159
artikel
74 Inhibition of Human Cytomegalovirus DNA Replication with a Phosphorothioate Cholesteryl-Modified Oligonucleotide is Mediated by Rapid Cellular Association and Virus-Facilitated Nuclear Localization Zhang, Z
1997
3 p. 255-264
artikel
75 Inhibition of Human Cytomegalovirus Proteinase by Salcomine Derivatives Watanabe, S
1998
3 p. 269-274
artikel
76 Inhibition of Human T-Lymphotropic Virus Type I Gene Expression by the Streptomyces-Derived Substance EM2487 Wang, X
2002
3 p. 177-183
artikel
77 Inhibition of Influenza Virus A/WSN Replication by Serine Protease Inhibitors and anti-Protease Antibodies Someya, A.
1994
3 p. 187-190
artikel
78 Inhibition of Influenza Virus Replication by Constrained Peptides Targeting Nucleoprotein Jiang, Hongbing
2011
3 p. 119-130
artikel
79 Inhibition of Phlebovirus Infections in vivo by Tiazofurin and Selenazofurin Smee, D. F.
1990
3 p. 211-216
artikel
80 Inhibition of the Binding of HIV rgp120 to CD4 by Dyes Weaver, J. L.
1992
3 p. 147-151
artikel
81 Inhibition of the Cellular Rev Response and HIV-1 Replication by 8-Alkyl-2-(4-pyridyl)pyrido[2,3-d pyrimidin-5(8H)-Ones Ciccarelli, R. B.
1994
3 p. 169-175
artikel
82 Inhibition of the Production of HIV-1 from Chronically Infected H9 Cells by Metal Compounds and Their Complexes with L-cysteine or N-acetyl-L-cysteine Mahmood, N.
1995
3 p. 187-189
artikel
83 Inhibition of Thymidylate Synthetase Activity Induced in Varicella-Zoster Virus Infected Cells by (E)-5-(2-bromovinyl)-2′-deoxyuridine Yokota, T.
1994
3 p. 191-194
artikel
84 Inhibitors of Measles Virus Barnard, Dale L
2004
3 p. 111-119
artikel
85 Inhibitory Effect of Medicinal Herbs against RNA and DNA Viruses Ruffa, María Julieta
2004
3 p. 153-159
artikel
86 Inhibitory Effect of Pyridobenzoazoles on Orthomyxo-and Paramyxovirus Replication in vitro Shigeta, S.
1992
3 p. 171-177
artikel
87 Inhibitory Effects of Novel Mannose-Binding Lectins on HIV-Infectivity and Syncytium Formation Animashaun, T.
1993
3 p. 145-153
artikel
88 Inhibitory Effects of Novel Nucleoside and Nucleotide Analogues on Epstein—Barr Virus Replication Meerbach, A
1998
3 p. 275-282
artikel
89 Inhibitory Effects of Podophyllotoxin Derivatives on Herpes Simplex Virus Replication Sudo, K
1998
3 p. 263-267
artikel
90 Intermittent Zidovudine Regimen in Patients with Symptomatic HIV Infection and Previous Haematological Toxicity Williams, I. G.
1993
3 p. 139-143
artikel
91 Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz Jordaan, Maryam A
2017
3 p. 94-104
artikel
92 In vitro Anti-HIV-1 Activity of sn-2-Substituted 1-O-Octadecyl-sn-Glycero-3-Phosphonoformate Analogues and Synergy with Zidovudine Hostetler, Karl Y
2000
3 p. 213-219
artikel
93 In vitro Antiviral Activity and Cytotoxicity of Aspirin: Lack of Selective Activity against Influenza a Virus or Rhinovirus Crump, C. E.
1990
3 p. 217-221
artikel
94 In Vitro Pre- and Post-Exposure Prophylaxis Using HIV Inhibitors as Microbicides Against Cell-Free or Cell-Associated HIV-1 Infection Terrazas-Aranda, Katty
2007
3 p. 141-151
artikel
95 In vitro Sensitivity of Kaposi's Sarcoma Cells to Various Chemotherapeutic Agents Including Acyclic Nucleoside Phosphonates Simonart, Thierry
1999
3 p. 129-134
artikel
96 Los Alamos Hepatitis C Virus Sequence and Human Immunology Databases: An Expanding Resource for Antiviral Research Hraber, Peter T
2007
3 p. 113-123
artikel
97 Mechanism of Interaction of Novel Indolylarylsulfone Derivatives with K103N and Y181I Mutant HIV-1 Reverse Transcriptase in Complex with its Substrates Samuele, Alberta
2011
3 p. 107-118
artikel
98 Mechanism of the Antiviral Activity of New Aurintricarboxylic Acid Analogues Reymen, D.
1996
3 p. 142-152
artikel
99 Metabolism of 3′-Azido-3′-Deoxythymidine and 3′-Fluoro-3′-Deoxythymidine in Combination in Human Immunodeficiency Virus Infected Lymphoblastoid Cells Cox, S.
1992
3 p. 165-170
artikel
100 Modified Cyclodextrin Sulphates(mCDS11) have Potent Inhibitory Activity against HIV and High Oral Bioavailability Otake, T.
1994
3 p. 155-161
artikel
101 Molecular and Biological Aspects of AZT Resistant Viruses Derived from HIV-1 Infected Individuals Levantis, P.
1993
3 p. 131-138
artikel
102 Mouse Model of Respiratory Syncytial Virus Infection to Evaluate Antiviral Activity in Vivo Sudo, Kenji
1999
3 p. 135-139
artikel
103 Multi-Branched Peptide Constructs (MBPC) of the V3 Loop of Envelope Glycoprotein gp120 Inhibit Human Immunodeficiency Virus-Induced Syncytium Formation Benjouad, A.
1994
3 p. 195-196
artikel
104 Nucleoside diphosphate and triphosphate prodrugs – An unsolvable task? Meier, Chris
2017
3 p. 69-82
artikel
105 Oxathiin Carboxanilide Derivatives: A Class of Non-Nucleoside HIV-1-Specific Reverse Transcriptase Inhibitors (NNRTIs) that are Active against Mutant HIV-1 Strains Resistant to other NNRTIs Balzarini, J.
1995
3 p. 169-178
artikel
106 Penciclovir Pharmacokinetics and Distribution to the Brain and Muscle of Rats, Studied by Microdialysis Borg, N
1997
3 p. 275-279
artikel
107 Pharmacokinetic Enhancement of the Hepatitis C Virus Protease Inhibitors VX-950 and SCH 503034 by Co-Dosing with Ritonavir Kempf, Dale J
2007
3 p. 163-167
artikel
108 Pharmacokinetic Evaluation of anti-HIV Drug Interactions: Effect of Zidovudine on 2′-3′-Dideoxyinosine Kinetics in Monkeys Qian, M.
1993
3 p. 155-159
artikel
109 Pharmacokinetics of Bis(t-butyl-SATE)-AZTMP, a Bispivaloylthioethyl Prodrug for Intracellular Delivery of Zidovudine Monophosphate, in Mice Tan, Xiaolei
2000
3 p. 203-211
artikel
110 Phenylboronic-Acid-Based Carbohydrate Binders as Antiviral Therapeutics: Bisphenylboronic Acids Trippier, Paul C
2011
3 p. 129-142
artikel
111 Physicochemical Properties, Bioconversion and Disposition of Lipophilic Prodrugs of 2′,3′-Dideoxycytidine Ibrahim, S.S.
1996
3 p. 167-172
artikel
112 Polysulfonates Derived from Metal Thiolate Complexes as Inhibitors of HIV-1 and Various other Enveloped Viruses In Vitro Bergstrom, Donald E
2002
3 p. 185-195
artikel
113 5′Prime;-Ester Prodrugs of the Varicella-Zoster Antiviral Agent, 6-Methoxypurine Arabinoside Moorman, A. R.
1992
3 p. 141-146
artikel
114 Probing the Mechanistic Consequences of 5-Fluorine Substitution on Cytidine Nucleotide Analogue Incorporation by HIV-1 Reverse Transcriptase Ray, Adrian S
2003
3 p. 115-125
artikel
115 Progress in the Discovery of Compounds Inhibiting Orthopoxviruses in Animal Models Smee, Donald F
2008
3 p. 115-124
artikel
116 Purine Arabinosides as Inhibitors of Human Haemopoietic Progenitor Cells Averett, D. R.
1992
3 p. 179-182
artikel
117 Retrovirus Reverse Transcriptases Containing a Modified YXDD Motif Sharma, Prem L
2005
3 p. 169-182
artikel
118 Reverse Transcriptase-Associated Ribonuclease H Activity as a Target for Antiviral Chemotherapy Rausch, JW
1997
3 p. 173-185
artikel
119 Review Hepatitis B Virus Resistance to Lamivudine and its Clinical Implications Liu, Xuefeng
2002
3 p. 143-155
artikel
120 Role of Lentiviral Lytic Polypeptide I (LLP-I) in the Selective Cytotoxicity of γ-Glutamylcysteine Ethyl Ester against Human Immunodeficiency Virus Type 1-Producing Cells Kubota, Satoshi
1999
3 p. 121-126
artikel
121 Selective Anti-Herpesvirus Agents De Clercq, Erik
2013
3 p. 93-101
artikel
122 Selective Killing of HIV-Infected Cells by Liposomes Composed of dimyristoylphosphatidylcholine/phosphatidylserine/cholesterol Kumagai, K.
1991
3 p. 143-148
artikel
123 Side-Chain Derivatives of Biologically Active Nucleosides. Part 2: Synthesis and anti-HIV Activity of 5′-C-Methyl Derivatives of 3′-Fluoro-3′-Deoxythymidine Hiebl, J.
1996
3 p. 173-177
artikel
124 Sodium Deoxycholate Exerts a Direct Destructive Effect on HIV and Influenza Viruses in vitro and Inhibits Retrovirus-Induced Pathology in An Animal Model Oxford, J. S.
1994
3 p. 176-181
artikel
125 Specific Inhibition of Influenza Virus RNA Polymerase and Nucleoprotein Gene Expression by Liposomally Encapsulated Antisense Phosphorothioate Oligonucleotides in MDCK Cells Abe, T
1998
3 p. 253-262
artikel
126 Stability of the Herpesvirus Ribonucleotide Reductase-Inhibiting Nonapeptide YAGAVVNDL in Extracts of HSV-1-Infected Cells Telford, E.
1990
3 p. 223-226
artikel
127 Stereochemical Aspects of the anti-HCMV Activity of Cytidine Nucleoside Analogues Mansour, T. S.
1995
3 p. 138-142
artikel
128 Structural Features and Antiviral Activity of Sulphated Fucans from the Brown Seaweed Cystoseira Indica Mandal, Pinaki
2007
3 p. 153-162
artikel
129 5-Substituted-2′-deoxyuridines as anti-HSV-1 Agents: Synthesis and Structure Activity Relationship Herdewijn, P. A. M. M.
1994
3 p. 131-146
artikel
130 Sulphated and Sulphonated Polymers Inhibit the Initial Interaction of Hepatitis B Virus with Hepatocytes Ying, C
2002
3 p. 157-164
artikel
131 Suppression of HIV-1 Replication by a 4-H-Quinolizine Derivative Ohnota, H.
1991
3 p. 187-190
artikel
132 Synergistic Inhibition of Human Immunodeficiency Virus Type 1 in vitro by 6-0-butanoylcastanospermine (MDL 28574) in Combination with Inhibitors of the Virus-Encoded Reverse Transcriptase and Proteinase Taylor, D. L.
1995
3 p. 143-152
artikel
133 Synergistic Inhibition of Human Immunodeficiency Virus Type 1 in vitro by Interferon Alpha and Coumermycin A1 Tachedjian, G.
1992
3 p. 183-188
artikel
134 Synthesis and an Antiviral Activity Evaluation of Nucleoside 5′-O-(N-acyl) Phosphoramidates Kulik, Katarzyna
2011
3 p. 143-150
artikel
135 Synthesis and Antiviral Activity of Some 5′-N-Phthaloyl-3′-Azido-2′,3′-Dideoxythymidine Analogues Balzarini, Jan
2003
3 p. 139-144
artikel
136 Synthesis and Antiviral Evaluation of Fluorinated Dipyridodiazepinones and Dipyridodiazepines (Nevirapine Derivatives) Boyode, B. P.
1995
3 p. 162-168
artikel
137 Synthesis and Enantioselectivity of the Antiviral Effects of (R,Z)-,(S,Z)-methylenecyclopropane Analogues of Purine Nucleosides and Phosphoralaninate Prodrugs: Influence of Heterocyclic Base, Type of Virus and Host Cells Qiu, Y-L
2000
3 p. 191-202
artikel
138 Synthesis and Evaluation of Some Masked Phosphate Esters of the Anti-Herpesvirus Drug 882C (Netivudine) as Potential Antiviral Agents McGuigan, C
1998
3 p. 233-243
artikel
139 Synthesis and Structure Activity Relationships of a Series of Penicillin-Derived Pseudosymmetric Inhibitors of HIV-1 Proteinase Humber, D. C.
1994
3 p. 197-200
artikel
140 Synthesis, Biological Activity, Pharmacokinetic Properties and Molecular Modelling Studies of Novel 1H,3H-Oxazolo[3,4-a]Benzimidazoles: Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors Chimirri, A
2001
3 p. 169-174
artikel
141 Synthesis of 2′- and 3′-Amino-Substituted Uridine, Thymidine and Adenosine, and Their Inhibitions of HIV Replication Vial, J.-M.
1990
3 p. 183-202
artikel
142 Synthesis of Nucleosidyl Rifamycins as Inhibitors of Human Immunodeficiency Virus Type 1 Bartolucci, C
1997
3 p. 215-221
artikel
143 Synthesis, Oral Bioavailability and in vivo Activity of Acetal Derivatives of the Selective Antiherpesvirus Agent 9-(3-hydroxypropoxy) Guanine (BRL 44385) Harnden, M. R.
1994
3 p. 147-154
artikel
144 Synthesis, Solution Conformation and Anti-HIV Activity of Novel 3-Substituted-2′,3′-Dideoxy-5-Hydroxymethyl-Uridines and Their 4,5-Substituted Analogues Poznanski, Jaroslaw
2003
3 p. 127-138
artikel
145 Targeting RNase L to Human Immunodeficiency Virus RNA with 2-5A-Antisense Player,
1998
3 p. 225-231
artikel
146 The Enantioselectivity of Enzymes Involved in Current Antiviral Therapy Using Nucleoside Analogues: A New Strategy? Maury, Georges
2000
3 p. 165-189
artikel
147 The Enzymatic Synthesis and Anti-HIV Activity of 9-β-D-2-Deoxy and 9-β-D-2′,3′-Dideoxynucleossdes of 2-Aminopurine Hicks, N.
1992
3 p. 153-156
artikel
148 The Inhibitor of Cyclin-Dependent Kinases, Olomoucine II, Exhibits Potent Antiviral Properties Holcakova, Jitka
2010
3 p. 133-142
artikel
149 The Intracellular Formation of a Mononucleotide of the Anti-Influenza Agent 1,3,4-thiadiazol-2-ylcyanamide (LY217896) Birch, G. M.
1995
3 p. 127-137
artikel
150 Therapeutic Targeting of HCV Internal Ribosomal Entry Site RNA Davis, Darrell R
2011
3 p. 117-128
artikel
151 The Thiocarboxanilides UC-10 and UC-781 Have an Additive Inhibitory Effect against Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Replication in Cell Culture When Combined with other Antiretroviral Drugs Balzarini, J
1997
3 p. 197-204
artikel
152 Thienothiadiazine 2,2-Dioxide Acyclonucleosides: Synthesis and Antiviral Activity Martinez, A
2000
3 p. 221-230
artikel
153 Three-Drug Combinations of Emivirine and Nucleoside Reverse Transcriptase Inhibitors in Vitro: Long-Term Culture of HIV-1-Infected Cells and Breakthrough Viruses Nitanda, T
2001
3 p. 161-167
artikel
154 Treatment of Visna Virus Infection in Lambs with the Acyclic Nucleoside Phosphonate Analogue 9-(2-Phosphonylmethoxyethyl)Adenine (PMEA) Thormar, H
1998
3 p. 245-252
artikel
155 Trial of Antisense RNA Inhibition of HIV Replication and Gene Expression Shimada, T.
1991
3 p. 133-142
artikel
156 TSAO Derivatives the First Non-Peptide Inhibitors of HIV-1 RT Dimerization Camarasa, María-José
2005
3 p. 147-153
artikel
157 Viral Pharmacodynamic Model for (–)-β-2′,3′-Dideoxy-5-Fluoro-3′-Thiacytidine (Emtricitabine) in Chronically Infected Woodchucks Hurwitz, Selwyn J
2002
3 p. 165-176
artikel
158 Viramidine, a Prodrug of Ribavirin, Shows Better Liver-Targeting Properties and Safety Profiles Than Ribavirin in Animals Lin, Chin-Chung
2003
3 p. 145-152
artikel
                             158 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland